Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19.

Ormhøj M, Scarfò I, Cabral ML, Bailey SR, Lorrey SJ, Bouffard AA, Castano AP, Larson RC, Riley LS, Schmidts A, Choi BD, Andersen RS, Cédile O, Nyvold CG, Christensen JH, Gjerstorff MF, Ditzel HJ, Weinstock DM, Barington T, Frigault MJ, Maus MV.

Clin Cancer Res. 2019 Aug 22. doi: 10.1158/1078-0432.CCR-19-1337. [Epub ahead of print]

PMID:
31439577
2.

CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity.

Choi BD, Yu X, Castano AP, Bouffard AA, Schmidts A, Larson RC, Bailey SR, Boroughs AC, Frigault MJ, Leick MB, Scarfò I, Cetrulo CL, Demehri S, Nahed BV, Cahill DP, Wakimoto H, Curry WT, Carter BS, Maus MV.

Nat Biotechnol. 2019 Sep;37(9):1049-1058. doi: 10.1038/s41587-019-0192-1. Epub 2019 Jul 22.

PMID:
31332324
3.

Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response.

Baeuerle PA, Ding J, Patel E, Thorausch N, Horton H, Gierut J, Scarfo I, Choudhary R, Kiner O, Krishnamurthy J, Le B, Morath A, Baldeviano GC, Quinn J, Tavares P, Wei Q, Weiler S, Maus MV, Getts D, Schamel WW, Hofmeister R.

Nat Commun. 2019 May 7;10(1):2087. doi: 10.1038/s41467-019-10097-0.

4.

CAR-Based Approaches to Cutaneous T-Cell Lymphoma.

Scarfò I, Frigault MJ, Maus MV.

Front Oncol. 2019 Apr 16;9:259. doi: 10.3389/fonc.2019.00259. eCollection 2019. Review.

5.

Transcatheter or surgical repair for degenerative mitral regurgitation in elderly patients: A propensity-weighted analysis.

Buzzatti N, Van Hemelrijck M, Denti P, Ruggeri S, Schiavi D, Scarfò IS, Reser D, Taramasso M, Weber A, La Canna G, De Bonis M, Maisano F, Alfieri O.

J Thorac Cardiovasc Surg. 2019 Jul;158(1):86-94.e1. doi: 10.1016/j.jtcvs.2019.01.023. Epub 2019 Jan 22.

PMID:
30797588
6.

Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing.

Kleinstiver BP, Sousa AA, Walton RT, Tak YE, Hsu JY, Clement K, Welch MM, Horng JE, Malagon-Lopez J, Scarfò I, Maus MV, Pinello L, Aryee MJ, Joung JK.

Nat Biotechnol. 2019 Mar;37(3):276-282. doi: 10.1038/s41587-018-0011-0. Epub 2019 Feb 11.

7.

A Subtle Clinical Phenotype of Aortic Limited Intimal Tear Without Hematoma.

La Canna G, Formisano T, Monti L, Torracca L, Scarfò I.

JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 1):1572-1577. doi: 10.1016/j.jcmg.2018.11.012. Epub 2019 Jan 16. No abstract available.

PMID:
30660523
8.

Mid-term outcomes (up to 5 years) of percutaneous edge-to-edge mitral repair in the real-world according to regurgitation mechanism: A single-center experience.

Buzzatti N, Denti P, Scarfò IS, Giambuzzi I, Schiavi D, Ruggeri S, Castiglioni A, De Bonis M, La Canna G, Alfieri O.

Catheter Cardiovasc Interv. 2018 Dec 27. doi: 10.1002/ccd.28029. [Epub ahead of print]

PMID:
30592134
9.

Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas.

Scarfò I, Ormhøj M, Frigault MJ, Castano AP, Lorrey S, Bouffard AA, van Scoyk A, Rodig SJ, Shay AJ, Aster JC, Preffer FI, Weinstock DM, Maus MV.

Blood. 2018 Oct 4;132(14):1495-1506. doi: 10.1182/blood-2018-04-842708. Epub 2018 Aug 8. Erratum in: Blood. 2018 Dec 6;132(23):2527.

10.

MitraClip for radiotherapy-related mitral valve regurgitation.

Scarfò I, Denti P, Citro R, Buzzatti N, Alfieri O, La Canna G.

Hellenic J Cardiol. 2018 Jul 26. pii: S1109-9666(18)30237-9. doi: 10.1016/j.hjc.2018.07.006. [Epub ahead of print]

11.

[2017 ESC guidelines on valvular heart disease: what's new?]

La Canna G, Scarfò I.

G Ital Cardiol (Rome). 2018 Jul-Aug;19(7):405-411. doi: 10.1714/2938.29536. Italian. No abstract available.

PMID:
29989597
12.

How to differentiate functional from degenerative mitral regurgitation.

La Canna G, Scarfo' I, Caso I.

J Cardiovasc Med (Hagerstown). 2018 Feb;19 Suppl 1:e75-e79. doi: 10.2459/JCM.0000000000000579. Review. No abstract available.

PMID:
29538148
13.

Unilateral Pulmonary Edema in a Patient with Worsening Tricuspid Valve Regurgitation: A Secret Inside Pulmonary Veins.

Resciniti E, Caso I, Scarfò I, Pasquale GD, Canna G.

J Cardiovasc Echogr. 2017 Oct-Dec;27(4):153-155. doi: 10.4103/jcecho.jcecho_26_17.

14.

Three-dimensional echocardiography diagnosis of double perforation of bicuspid aortic valve.

Longobardo L, Coluccia V, Azzu A, Scarfò IS, Alfieri O, La Canna G.

J Cardiovasc Med (Hagerstown). 2017 Oct;18(10):841-842. doi: 10.2459/JCM.0000000000000547. No abstract available.

PMID:
28817398
15.

Current approaches to increase CAR T cell potency in solid tumors: targeting the tumor microenvironment.

Scarfò I, Maus MV.

J Immunother Cancer. 2017 Mar 21;5:28. doi: 10.1186/s40425-017-0230-9. eCollection 2017. Review.

16.

Does implantation of a single clip provide reliable durability after transcatheter mitral repair?

Buzzatti N, Denti P, La Canna G, Schiavi D, Vicentini L, Scarfò IS, Caso I, De Bonis M, Alfieri O.

Eur J Cardiothorac Surg. 2017 Jul 1;52(1):137-142. doi: 10.1093/ejcts/ezx044.

PMID:
28329199
17.

Is pulmonary artery pressure a trigger of adverse outcome in mitral regurgitation?

Scarfò I, La Canna G.

Ann Transl Med. 2016 Dec;4(24):498. doi: 10.21037/atm.2016.12.36. No abstract available.

18.

The heterogeneous landscape of ALK negative ALCL.

Mereu E, Pellegrino E, Scarfò I, Inghirami G, Piva R.

Oncotarget. 2017 Mar 14;8(11):18525-18536. doi: 10.18632/oncotarget.14503. Review.

19.

The RNA-binding protein ESRP1 promotes human colorectal cancer progression.

Fagoonee S, Picco G, Orso F, Arrigoni A, Longo DL, Forni M, Scarfò I, Cassenti A, Piva R, Cassoni P, Silengo L, Tolosano E, Aime S, Taverna D, Pandolfi PP, Brancaccio M, Medico E, Altruda F.

Oncotarget. 2017 Feb 7;8(6):10007-10024. doi: 10.18632/oncotarget.14318.

20.

Transposable elements: The enemies within.

Scarfò I, Pellegrino E, Mereu E, Inghirami G, Piva R.

Exp Hematol. 2016 Oct;44(10):913-6. doi: 10.1016/j.exphem.2016.06.251. Epub 2016 Jul 1. Review.

PMID:
27377925
21.

Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts.

Scarfò I, Pellegrino E, Mereu E, Kwee I, Agnelli L, Bergaggio E, Garaffo G, Vitale N, Caputo M, Machiorlatti R, Circosta P, Abate F, Barreca A, Novero D, Mathew S, Rinaldi A, Tiacci E, Serra S, Deaglio S, Neri A, Falini B, Rabadan R, Bertoni F, Inghirami G, Piva R; European T-Cell Lymphoma Study Group.

Blood. 2016 Jan 14;127(2):221-32. doi: 10.1182/blood-2014-12-614503. Epub 2015 Oct 13.

PMID:
26463425
22.

The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma.

Piva R, Deaglio S, Famà R, Buonincontri R, Scarfò I, Bruscaggin A, Mereu E, Serra S, Spina V, Brusa D, Garaffo G, Monti S, Dal Bo M, Marasca R, Arcaini L, Neri A, Gattei V, Paulli M, Tiacci E, Bertoni F, Pileri SA, Foà R, Inghirami G, Gaidano G, Rossi D.

Leukemia. 2015 Feb;29(2):503-7. doi: 10.1038/leu.2014.294. Epub 2014 Oct 6. No abstract available.

PMID:
25283840
23.

An increased endothelial-independent vasodilation is the hallmark of the neurally mediated syncope.

Santini L, Capria A, Brusca V, Violo A, Smurra F, Scarfò I, Forleo GB, Papavasileiou LP, Borzi M, Romeo F.

Clin Cardiol. 2012 Feb;35(2):107-10. doi: 10.1002/clc.20990. Epub 2011 Nov 28.

Supplemental Content

Loading ...
Support Center